The Consumer Brief Summary: FDA’s New Thinking Regarding Risk Communication

New FDA guidelines jettison the 'traditional approach' to fulfilling the brief summary requirement and replaces it with what the FDA calls the 'Consumer Brief Summary.' This article summarizes the new guidelines and reviews the need for additional guidelines that specifically address the fair balance section of DTC print ads.

Patient Centricity, Transparency, & Pharma’s Reputation: Getting Beyond Lip Service

This article discusses real world examples of patient-centricity in pharmaceutical marketing and the need for more transparency in how pharmaceutical companies partner with patients online.

A KOL by Any Other Name: Too Toxic for Everyday Use, or Still the...

This article summarizes the results of the KOL Name Change Survey and discusses how to change the underlying process by which pharma companies choose KOLs.

Pharma Marketing News Vol. 14, No. 3: April 2015

Welcome to Vol. 14, Issue No. 3 (APRIL 2015) of Pharma Marketing News. Patient centricity, direct-to-consumer advertising, and key opinion leaders are the focus of this issue. All are related in the sense that each area has seen major changes & shifts in thinking with more to come.

The Mobile Health Library™: Apps for Rx Adherence & Outcomes Support

Rob Dhoble, CEO of Adherent Health, is interviewed about his company's Mobile Health Library (MHL) mHealth platform, which is built specifically for the education and support of patients and caregivers. MHL offers many features for creating cost-effective mobile apps for Rx brand adherence and outcomes support.

Wearables, Ingestibles, Implantables: The Inescapable Future of Healthcare

This article discusses the intrusiveness of wearables et al and other issues of these technologies as they relate to healthcare outcomes and communications arena and whether pharma marketers should get on the bandwagon.

2014 Was a Good Year for FDA & Pharma: Banging Year for Drug Approvals,...

The FDA approved a total of 41 new molecular entities (NMEs) and biologics (BLAs) in 201 4but sent out only a meager 10 advertising enforcement letters in 2014, the fewest ever.

How to Achieve Digital Pharma Marketing Results: Dealing with Disruption

This article focuses on digital disruption, which is the focus of a chapter in the book RESULTS: The Future of Pharmaceutical and Healthcare Marketing written by by R.J. Lewis (aka RJ) et al.

The Patients Included Initiative & Pharma: Pharma Should Offer Continuing Patient Education Grants

One of the guidelines of the Patients Included charter requires scholarships for patient to attend medical and pharma industry conferences. But who will pay the way for patients to attend and how will the scholarships be administered? This article discusses that issue and suggests that the pharmaceutical industry, which claims to be 'patient centric,' can play a role by sponsoring Patients Included scholarships similar to how they sponsor physician continuing medical education programs for physicians.

Pharma Marketing: The Year 2015 in Images

Pharmaguy's Favorite Images with Commentary from Pharma Marketing Blog, Pharma Marketing News, and Scoops
- Advertisement -